Evidence map›Paper›PMID 40210596›Full record

ArticleClinical genetics2025

Infantile Cerebellar-Retinal Degeneration Associated With Novel ACO2 Variants: Clinical Features and Insights From a Drosophila Model.

Edgar Buhl, Suchika Garg, Marie Monaghan, Amy Preston, Marcus Likeman, Julianne Dare, Julie Evans, Lucie S Taylor, Ian Berry, Kathryn Urankar and 6 more

Abstract readCase Reports
In one paragraph

Article in Clinical genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Edgar BuhlSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.ORCID 0000-0003-1274-5870
Suchika GargDepartment of Paediatric Neurology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.ORCID 0000-0002-7297-5494
Marie MonaghanDepartment of Paediatric Neurology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.ORCID 0000-0002-1114-8495
Amy PrestonSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.ORCID 0009-0003-9723-8305
Marcus LikemanDepartment of Paediatric Neuroradiology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Julianne DareDepartment of Community Paediatrics, Community Children's Health Partnership, Kingswood Locality Hub, Bristol, UK.
Julie EvansBristol Genetics Laboratory, North Bristol NHS Trust, Bristol, UK.
Lucie S TaylorMitochondrial Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Ian BerryBristol Genetics Laboratory, North Bristol NHS Trust, Bristol, UK.
Kathryn UrankarDepartment of Neuropathology, North Bristol Hospital NHS Foundation Trust, Bristol, UK.
Paul G D SpryDepartment of Paediatric Ophthalmology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Cathy WilliamsDepartment of Paediatric Ophthalmology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Robert W TaylorMitochondrial Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.ORCID 0000-0002-7768-8873
Charlotte L AlstonMitochondrial Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.ORCID 0000-0003-2095-5464
James J L HodgeSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.ORCID 0000-0003-4741-2363
Anirban MajumdarDepartment of Paediatric Neurology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.ORCID 0000-0001-8521-1138

Funding

Biotechnology and Biological Sciences Research Council BB/W000865/1LifeArcLily FoundationMedical Research Council MR/W019027/1Mitochondrial Disease Patient Cohort G0800674National Institute for Health and Care Research PDF-2018-11-ST2-021Pathological Society of Great Britain and IrelandUK NHS Highly Specialised Service for Rare Mitochondrial DisordersUK NIHR Biomedical Research Centre for Ageing and Age-related diseaseWellcome TrustWellcome Trust Centre for Mitochondrial Research 203105/Z/16/Z
6 · The paper itself

Abstract

Infantile Cerebellar-Retinal Degeneration (ICRD) is an autosomal recessive neuro-disability associated with hypotonia, seizures, optic atrophy, and retinal degeneration. Recessive variants of the mitochondrial aconitase gene (ACO2) are a known cause of ICRD. Here, we present a paediatric male patient with ICRD, where whole genome sequencing of the family trio revealed segregating heterozygous variants of unknown significance in ACO2. At 4 months, he displayed generalised hypotonia, and by 6 years, visual electrophysiology indicated bilateral optic atrophy. Magnetic Resonance Imaging (MRI) at age seven confirmed optic nerve and cerebellar atrophy, and together with symptoms of developmental delay, align with ICRD. We established a Drosophila animal model to explore the impact of ACO2 loss- and gain-of-function. Manipulating the fly ortholog, mAcon1, through pan-neuronal knock-down or over-expression negatively affected longevity, locomotion, activity, whilst disrupting sleep and circadian rhythms. Mis-expression of mAcon1 in the eye led to impaired visual synaptic transmission and neurodegeneration. These experiments mirrored certain aspects of the human disease, providing a foundation for understanding its biological processes and pathogenic mechanisms, and offering insights into potential targets to screen for future treatments or preventive measures for ACO2-related ICRD.

Indexed as

Aconitate HydrataseRetinal DegenerationAnimalsChildDisease Models, AnimalDrosophilaHumansMagnetic Resonance ImagingMaleMutationPedigreePhenotypeACO2 protein, humanAconitate HydrataseACO2Drosophila melanogasterERGinfantile cerebellar‐retinal degenerationlocomotionmAcon1MRIoptic atrophysleep

Identifiers

PMID40210596
PMCPMC12319146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.